John Dileo, Ph.D is a Senior Principal Biotechnologist and Manager of MITRE's Biotechnology and Life Science Department. In this role he oversees department efforts in the areas of biosafety, security and quality, c-WMD, medical countermeasures development, and human performance optimization and manages MITRE’s Biotechnology Horizon Strategy.As a researcher, Dr. Dileo has led experimental and theoretical efforts in molecular, systems, and synthetic biology focused on developing cell based sense and respond systems and tools for screening orders for synthetic DNA for the presence of biosecurity threats. As a subject matter expert and project lead, Dr. Dileo has provided support and oversight to numerous large US Government research and development programs at DARPA BTO, DTRA, JPEO-CBRND, DHS S&T, and other national security organizations. Specific efforts have focused on assessing the national security implications of emerging developments in biotechnology, preventing the proliferation and use of biological weapons, biomanufacturing, and working with USG program managers to develop and execute novel program/project concepts.Prior to joining MITRE, Dr. Dileo was a research fellow in the Department of Urology at Pittsburgh Cancer Institute. There his research focused on developing gene based immunotherapies for cervical and prostate cancer and novel gene delivery methods. Dr. Dileo received his Ph.D. in Molecular Genetics & Biochemistry in 2001 from the University of Pittsburgh School of Medicine.